Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Error message

    • Deprecated function: Return type of DatabaseStatementBase::execute($args = [], $options = []) should either be compatible with PDOStatement::execute(?array $params = null): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2246 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::current() should either be compatible with Iterator::current(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::next() should either be compatible with Iterator::next(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::key() should either be compatible with Iterator::key(): mixed, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::valid() should either be compatible with Iterator::valid(): bool, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).
    • Deprecated function: Return type of DatabaseStatementEmpty::rewind() should either be compatible with Iterator::rewind(): void, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in require_once() (line 2348 of /var/www/webmd/apps/mdedge/htdocs/includes/database/database.inc).

    Howard Wolinsky

    News

    Enzalutamide improves metastasis-free survival, QoL in prostate cancer

    Author:
    Howard Wolinsky
    Publish date: October 24, 2023

    “This is the first time we have seen this kind of results with a novel hormonal therapy without castration.”

    • Read More

    News

    Is this the best screening test for prostate cancer?

    Author:
    Howard Wolinsky
    Publish date: September 11, 2023

    Researchers from the United Kingdom found that half of men with apparently “safe” PSA levels had clinically significant prostate cancers when...

    • Read More

    News

    Predicting prostate cancer risk: Are polygenic risk scores ready for prime time?

    Author:
    Howard Wolinsky
    Publish date: September 6, 2023

    “A polygenic risk score estimates your risk by adding together the number of bad cards you were dealt by the impact of each card, such as an ace...

    • Read More

    News

    Urology groups endorse two prostate biopsy approaches

    Author:
    Howard Wolinsky
    Publish date: May 24, 2023

    “If you step out of the echo chamber, what you’ll find is that the accurate complications amongst the two procedures are not that dramatically...

    • Read More

    News

    Watching feasible for asymptomatic kidney stones

    Author:
    Howard Wolinsky
    Publish date: May 9, 2023

    Urologists can be comfortable watching small stones (2.4 mm or less in size, but any significantly larger than that (7-8 mm) should be managed...

    • Read More

    News

    Prostate biopsies a laughing (gas) matter?

    Author:
    Howard Wolinsky
    Publish date: May 2, 2023

    “At levels of less than 50%, patients respond normally to verbal commands and maintain normal airway reflexes.”

    • Read More

    News

    Wireless neurostimulation safe for urge incontinence

    Author:
    Howard Wolinsky
    Publish date: May 2, 2023

    More than three-quarters of the women who received the device responded to therapy at 1 year, and 84.6% of the patients showed improvement.

    • Read More

    News

    New cancer data spark outcry from patient advocates

    Author:
    Howard Wolinsky
    Publish date: January 30, 2023

    The American Cancer Society on Jan. 13 revealed what it called ‘alarming’ news about prostate cancer.

    • Read More

    News

    Mind the geriatrician gap

    Author:
    Howard Wolinsky
    Publish date: December 8, 2022

    In 2022, only 43% of the nation’s 177 geriatrics fellowship slots were filled.

    • Read More

    News

    ‘Medical Methuselahs’: Treating the growing population of centenarians

    Author:
    Howard Wolinsky
    Publish date: August 19, 2022

    Between 1980 and 2019, the share of American centenarians grew faster than the total population.

    • Read More

    News

    New guideline gives active surveillance a boost

    Author:
    Howard Wolinsky
    Publish date: May 19, 2022

    This is the first guidance for localized prostate cancer since 2017.

    • Read More

    News

    Most men with low-risk prostate tumors now forgoing treatment

    Author:
    Howard Wolinsky
    Publish date: May 17, 2022

    Roughly 60% of men eligible for active surveillance chose that approach in 2021, up from 27% in 2014 and less than 10% in 2010.

    • Read More

    News

    Metformin use linked to birth defects in boys

    Author:
    Howard Wolinsky
    Publish date: March 29, 2022

    “This is the first data to suggest that paternal metformin [use] may be associated with birth defects in children. As such, it would be early to...

    • Read More

    News

    U.S. primary care seen lagging in key markers

    Author:
    Howard Wolinsky
    Publish date: March 18, 2022

    In delivery of primary care, including access and coordination, the U.S. trails well behind 10 other wealthy countries, according to a new report...

    • Read More

    News

    Handheld ECGs ease AFib screening in the very elderly

    Author:
    Howard Wolinsky
    Publish date: March 10, 2022

    But the use of handheld, single-lead electrocardiograms (ECGs) did not increase diagnoses of AFib overall in patients aged 65 and older.

    • Read More

    Pages

    • 1
    • 2
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery